Alexander Karl
Overview
Explore the profile of Alexander Karl including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
105
Citations
1725
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Unterrainer L, Eismann L, Lindner S, Gildehaus F, Toms J, Casuscelli J, et al.
Eur J Nucl Med Mol Imaging
. 2024 Jan;
51(6):1786-1789.
PMID: 38236427
Introduction: [ Ga]Ga-FAPI-46 PET/CT is a novel hybrid imaging method that previously showed additional diagnostic value in the assessment of distant urothelial carcinoma lesions. We hypothesized that patients with bladder...
2.
Strobach D, Haimerl L, Mannell H, Stief C, Karl A, Grimm T, et al.
J Clin Med
. 2023 Nov;
12(21).
PMID: 37959213
We aimed to characterize non-oncologic chronic drug therapy of bladder cancer (BC) patients and evaluate a possible impact on recurrence-free (RFS) and cancer-specific survival (CSS). Patients with a first diagnosis...
3.
Ravichandran H, Knobloch T, Pannone A, Karl A, Stampfer B, Waldhoer D, et al.
ACS Nano
. 2023 Jul;
17(15):14449-14460.
PMID: 37490390
Defects play a pivotal role in limiting the performance and reliability of nanoscale devices. Field-effect transistors (FETs) based on atomically thin two-dimensional (2D) semiconductors such as monolayer MoS are no...
4.
Rodler S, Buchner A, Eismann L, Schulz G, Marcon J, Ledderose S, et al.
Res Rep Urol
. 2022 Aug;
14:281-290.
PMID: 35937307
Purpose: Absence of tumor in the final histopathology after radical cystectomy (RC) is a rare but potentially favorable outcome. Therefore, we aimed to analyze outcomes and prognostic factors of patients...
5.
Volz Y, Eismann L, Pfitzinger P, Westhofen T, Ebner B, Jokisch J, et al.
Clin Genitourin Cancer
. 2022 Apr;
20(4):e283-e290.
PMID: 35367155
Introduction: Radical cystectomy (RC) and urinary diversion by ileal conduit (IC) or ileal orthotopic neobladder (ONB) is the standard-of-care for surgical treatment of muscle-invasive bladder cancer. Yet, it is unclear...
6.
Unterrainer L, Lindner S, Eismann L, Casuscelli J, Gildehaus F, Bui V, et al.
Eur J Nucl Med Mol Imaging
. 2022 Mar;
49(10):3571-3580.
PMID: 35325283
Background: [Ga]Ga-FAPI-46 is a novel positron emission tomography (PET) ligand that targets fibroblast activation protein (FAP) expression as FAP inhibitor (FAPI) and could already show promising results in several tumor...
7.
Weinhold P, Jokisch F, Schulz G, Buchner A, Kazmierczak P, Kretschmer A, et al.
Urol Int
. 2022 Feb;
106(8):806-815.
PMID: 35114679
Introduction: Palliative radical cystectomy (pRC) may be offered to selected bladder cancer (BC) patients with grievous local symptoms. However, there is only scarce information on perioperative complications and prognosis, especially...
8.
Haimerl L, Strobach D, Mannell H, Stief C, Buchner A, Karl A, et al.
Int J Clin Pharm
. 2021 Nov;
44(2):339-347.
PMID: 34724148
Background Chronic drug therapy may impact recurrence and survival of patients with bladder cancer and thus be of concern regarding drug choice and treatment decisions. Currently, data are conflicting for...
9.
Zangl Q, Wirth J, Karl A, Stief C, Zwissler B, von Dossow V
Oncology (Williston Park)
. 2021 Oct;
35(9):620-627.
PMID: 34669360
Objectives: This work aims to evaluatecomprehensive geriatric assessment (CGA) tools to better guide patients with urogenital carcinomas perioperatively and, consequently, to intensify or reduce hospital resource use. Methods: After informed...
10.
Schulz G, Elezkurtaj S, Bording T, Schmidt E, Elmasry M, Stief C, et al.
Cancer Sci
. 2021 Mar;
112(5):1987-1996.
PMID: 33686706
Signaling pathways that drive bladder cancer (BC) progression may be promising and specific targets for systemic therapy. Here, we investigated the clinical significance and targetability of NOTCH and mitogen-activated protein...